Research progress in OX40/OX40L in allergic diseases

被引：0
|
作者：
Song, Rongrong [1 ]
Zhang, Huanlei [1 ]
Liang, Zhuoping [1 ]
机构：
[1] Southwest Med Univ, Affiliated Hosp, Dept Otolaryngol Head & Neck Surg, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China
来源：
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY | 2024年 / 14卷 / 12期
关键词：
allergic rhinitis; asthma; atopic dermatitis; OX40; OX40L; ATOPIC-DERMATITIS; RHINITIS; QUESTIONS; BLOCKADE;
D O I：
10.1002/alr.23469
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
OX40/OX40L are costimulatory molecules in the tumor necrosis factor superfamily. Numerous studies have shown that OX40/OX40L are involved in immune regulation, especially in the proliferation and differentiation of T cells and the generation of memory T cells, which play important roles in allergic diseases. In recent years, the use of OX40/OX40L as therapeutic targets for treating T-cell-mediated diseases has attracted the interest of scholars. This paper reviews the role of OX40/OX40L in allergic diseases and the progress in clinical treatments targeting this signaling pathway.
引用
收藏
页码：1921 / 1928
页数：8
相关论文
共 50 条
  • [41] An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors
    Wang, Rui
    Gao, Chan
    Raymond, Megan
    Dito, Gennaro
    Kabbabe, Dominic
    Shao, Xiao
    Hilt, Ed
    Sun, Yongliang
    Pak, Irene
    Gutierrez, Martin
    Melero, Ignacio
    Spreafico, Anna
    Carvajal, Richard D.
    Ong, Michael
    Olszanski, Anthony J.
    Milburn, Christina
    Thudium, Kent
    Yang, Zheng
    Feng, Yan
    Fracasso, Paula M.
    Korman, Alan J.
    Aanur, Praveen
    Huang, Shih-Min A.
    Quigley, Michael
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 6709 - 6720
  • [42] IL-33 Promotes the Induction and Maintenance of Th2 Immune Responses by Enhancing the Function of OX40 Ligand
    Murakami-Satsutani, Naoko
    Ito, Tomoki
    Nakanishi, Takahisa
    Inagaki, Noriko
    Tanaka, Akihiro
    Phan Thi Xuan Vien
    Kibata, Kayoko
    Inaba, Muneo
    Nomura, Shosaku
    ALLERGOLOGY INTERNATIONAL, 2014, 63 (03) : 443 - 455
  • [43] Exploring Synergy in Combinations of Tumor-Derived Vaccines That Harbor 4-1BBL, OX40L, and GM-CSF
    Manrique-Rincon, Andrea J.
    Beraldo, Camila M.
    Toscaro, Jessica M.
    Bajgelman, Marcio C.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [44] Could OX40 agonist antibody promote activation of the anti-tumor immune response in gastric cancer?
    Martins, Mario R.
    Santos, Rogerio L. D.
    Jatahy, Kleber D. N.
    Matta, Marina C. D.
    Batista, Thales P.
    Junior, Jose Iran C.
    Begnami, Maria D. F. S.
    Torres, Leuridan C.
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (05) : 840 - 844
  • [45] Synergy of vaccination and agonist OX40 treatment-toward a mechanism-driven combination of glioma immunotherapy
    Deumelandt, Katrin
    Platten, Michael
    Ochs, Katharina
    NEURO-ONCOLOGY, 2018, 20 (01) : 4 - 5
  • [46] OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation
    Salek-Ardakani, S
    Song, JX
    Halteman, BS
    Jember, AGH
    Akiba, H
    Yagita, H
    Croft, M
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (02) : 315 - 324
  • [47] Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: A possible role in asthma?
    Burgess, JK
    Carlin, S
    Pack, RA
    Arndt, GM
    Au, WW
    Johnson, PRA
    Black, JL
    Hunt, NH
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (04) : 683 - 689
  • [48] Correlation of OX40 ligand on B cells with serum total IgE and IL-4 levels by CD4+ T cells in allergic rhinitis
    Fouladi, S.
    Masjedi, M.
    Hakemi, M. G.
    Ghasemi, R.
    Eskandari, N.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2019, 47 (03) : 234 - 240
  • [49] MiR-138 regulates dendritic cells mediated Th2-type immune response by regulating the OX40L expression in asthma
    Huang, Li
    Wang, Meijuan
    Chen, Zhengrong
    Yan, Yongdong
    Gu, Wenjing
    Zhang, Xinxing
    Tan, Jiahong
    Sun, Huiming
    Ji, Wei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (11): : 10979 - 10988
  • [50] Combination blockade of OX40L and CD30L inhibits allergen-driven memory TH2 cell reactivity and lung inflammation
    Gracias, Donald T.
    Sethi, Gurupreet S.
    Mehta, Amit K.
    Miki, Haruka
    Gupta, Rinkesh K.
    Yagita, Hideo
    Croft, Michael
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (06) : 2316 - 2329
12345